Suit filed against Uber and others after allegedly suffering a violent attack at the hands of a hailed driver in downtown ...

N/A = not available. As you can see, some biotech CEOs made off like Wall Street tycoons in 2014, although how they got paid and whether they deserved their pay are both up for debate.

News GlobeNewswire NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations ...

Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.